These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11891485)

  • 1. Radiation protection issues of treating hyperthyroidism with 131 I in patients on haemodialysis.
    Homer L; Smith AH
    Nucl Med Commun; 2002 Mar; 23(3):261-4. PubMed ID: 11891485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and radioablation treatment of toxic multinodular goiter in a hemodialysis patient.
    Demko TM; Tulchinsky M; Miller KL; Cheung JY; Groff JA
    Am J Kidney Dis; 1998 Apr; 31(4):698-700. PubMed ID: 9531189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RADIATION PROTECTION IN THE RELEASE OF PATIENTS RECEIVING 131I TREATMENT.
    Mattar E; Salih MA; Alsafi K; Suliman II
    Radiat Prot Dosimetry; 2019 Dec; 187(4):499-508. PubMed ID: 31605121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential third-party radiation exposure from outpatients treated with 131I for hyperthyroidism.
    Matheoud R; Reschini E; Canzi C; Voltini F; Gerundini P
    Med Phys; 2004 Dec; 31(12):3194-200. PubMed ID: 15651602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine (131I) treatment of hyperthyroidism: radiation protection and quality assurance.
    Reiners C; Lassmann M
    Eur J Nucl Med; 1999 Jul; 26(7):683-5. PubMed ID: 10398814
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation exposure rate from 131I-treated hyperthyroid patients--a dynamic study, with data for up to 42 d post therapy.
    Mohammadi H
    Health Phys; 2005 May; 88(5):486-90. PubMed ID: 15824597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction periods for carers, comforters and members of the public in the treatment of hyperthyroidism.
    Mínguez P; Genolla J; Celeiro J; Fombellida JC
    Radiat Prot Dosimetry; 2013; 154(3):285-92. PubMed ID: 22929557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective method of measuring the radioactivity of [ 131I]-capsule prior to radioiodine therapy with significant reduction of the radiation exposure to the medical staff.
    Lützen U; Zhao Y; Marx M; Imme T; Assam I; Siebert FA; Culman J; Zuhayra M
    J Appl Clin Med Phys; 2016 Jul; 17(4):59-72. PubMed ID: 27455475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism.
    Robertson JS; Gorman CA
    J Nucl Med; 1976 Sep; 17(9):826-35. PubMed ID: 956897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism.
    Barrington SF; O'Doherty MJ; Kettle AG; Thomson WH; Mountford PJ; Burrell DN; Farrell RJ; Batchelor S; Seed P; Harding LK
    Eur J Nucl Med; 1999 Jul; 26(7):686-92. PubMed ID: 10398815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-131 treatment of hyperthyroidism in a patient on dialysis for chronic renal failure.
    Nibhanupudy JR; Hamilton W; Sridhar R; Talley GB; Chughtai GM; Ashayeri E; Goldson AL
    Am J Nephrol; 1993; 13(3):214-7. PubMed ID: 8213934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
    Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
    Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incorporation monitoring of employees of a radioiodine therapy ward. Is incorporation monitoring required for routine?].
    Happel C; Kratzel U; Selkinski I; Bockisch B; Etzel M; Korkusuz H; Sauter B; Staudt J; von Müller F; Grünwald F; Kranert WT
    Nuklearmedizin; 2013; 52(1):43-50. PubMed ID: 23348688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimizing radiation exposure from patients treated with iodine-131 for hyperthyroidism using a lead collar: a simple and effective approach.
    Loutfi I; Sakr M; Al-Shummari AM
    Med Princ Pract; 2003; 12(4):203-7. PubMed ID: 12966190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of radioiodine in nuclear medical therapy.
    Heinemann K; Vogt KJ; Friedrich W; Feinendegen LE
    Strahlentherapie; 1983 Aug; 159(8):490-4. PubMed ID: 6623561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75.
    Coover LR; Silberstein EB; Kuhn PJ; Graves MW
    J Nucl Med; 2000 Nov; 41(11):1868-75. PubMed ID: 11079497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation alarm at an airport after radioiodine therapy.
    Sinzinger H; Aiginger P; Neumann I; Havlik E
    Nucl Med Commun; 2005 Jan; 26(1):67-8. PubMed ID: 15604950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurement of 131I concentration in saliva of a patient and monitoring of exposure and contamination in a ward (author's transl)].
    Maekoshi H; Orito T; Nishizawa K; Ohara K; Watanabe T; Ohshima M
    Radioisotopes; 1979 Mar; 28(3):180-3. PubMed ID: 554180
    [No Abstract]   [Full Text] [Related]  

  • 19. Unexpected dose to the daughter of a patient treated with iodine-131 for hyperthyroidism.
    Molyvda-Athanasopoulou E; Karaveli M; Chatzigiannaki A; Gotzamani-Psarrakou A
    Hell J Nucl Med; 2007; 10(3):175-6. PubMed ID: 18084660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodialysis procedure in a patient treated with radioactive iodine].
    Brunet P; Bourrelly M; Mundler O; Bouvier C; Faure V; Opris A; Bouchouareb D; Indreies M; Ramananarivo P; Dussol B; Berland Y
    Nephrol Ther; 2008 Jun; 4(3):196-201. PubMed ID: 18272443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.